EQB (TSE:EQB – Get Free Report) had its price target dropped by Scotiabank from C$130.00 to C$119.00 in a research report issued on Thursday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Scotiabank’s target price suggests a potential upside of 15.87% from the company’s current price.
Several other research firms have also recently weighed in on EQB. CIBC raised their target price on shares of EQB from C$113.00 to C$130.00 in a research note on Tuesday, November 26th. Desjardins set a C$130.00 target price on shares of EQB and gave the company a “buy” rating in a research note on Tuesday, February 11th. BMO Capital Markets raised their target price on shares of EQB from C$106.00 to C$119.00 in a research note on Monday, November 18th. TD Securities cut shares of EQB from a “buy” rating to a “hold” rating and decreased their target price for the company from C$126.00 to C$110.00 in a research note on Friday, December 6th. Finally, Raymond James raised their target price on shares of EQB from C$112.00 to C$121.00 and gave the company an “outperform” rating in a research note on Friday, January 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of C$117.20.
View Our Latest Stock Report on EQB
EQB Trading Down 3.1 %
About EQB
EQB Inc formerly Equitable Group Inc trades on the Toronto Stock Exchange TSX: EQB and EQB.PR.C and serves over 360000 Canadians through its wholly owned subsidiary Equitable Bank Canadas Challenger Bank. Equitable Bank has grown to become the countrys eighth largest independent Schedule I bank with a clear mandate to drive real change in Canadian banking to enrich peoples lives.
See Also
- Five stocks we like better than EQB
- Financial Services Stocks Investing
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Invest in Biotech Stocks
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Stock Sentiment Analysis: How it Works
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for EQB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EQB and related companies with MarketBeat.com's FREE daily email newsletter.